News

Home > News

News

December 5, 2016
Meiji Seika Pharma and Solasia Pharma Announce License and Collaboration Agreement for episil® (PDF)
October 12, 2016
Solasia files New Medical Device Applications for episil® in Japan and China (PDF)
March 28, 2016
Solasia initiates Phase II Study of Darinaparsin (SP-02L) for T-Cell Lymphoma (PDF)
November 25, 2015
Lee’s Pharmaceutical (HK) Limited and Solasia Pharma Announce License, Promotional and Supply Agreement for Sancuso®
English (PDF) Chinese (PDF)
March 30, 2015
Solasia acquires exclusive license and distribution rights from Camurus for episil® oral liquid in Japan and China (PDF)
January 19, 2015
Meiji Seika Pharma and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin Injection (SP-02) (PDF)
July 31, 2014
ZIOPHARM and Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin (PDF)
October 31, 2013
"Product in Development" updated
January 30, 2013
New Executive Leadership, Clinical Activities, and China Operations (PDF)
October 26, 2011
Solasia Announces Initiation of Darinaparsin Injection(SP-02) Phase 1 Study (PDF)
March 8, 2011
ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia (PDF)
March 3, 2010
Solasia Pharma and Kyowa Hakko Kirin enter into a License Agreement for SP-01(Sancuso®)in Asia (PDF)
October 30, 2009
Completion of Phase I clinical trial of Sancuso® in Japanese volunteers (PDF)
June 1, 2009
Sancuso® clinical trial application filed in China (PDF)
April 1, 2009
Announcement of Office Move (PDF)
March 9, 2009
Clinical Development of Solasia’s first drug initiated in Japan – Clinical trials also planned for China (PDF)
October 1, 2008
JapanBridge changes name to Solasia Pharma K.K. to reflect focus on asian strategy (PDF)
May 23, 2008
JapanBridge (Current Solasia Pharma K.K.) and prostrakan partner to develop Sancuso® in japan, China & parts of south east asia (PDF)
September 22, 2007
JapanBridge, inc.(Current Solasia Pharma K.K.), signs alliance with Kyowa Hakko Kogyo co., ltd.; closes $6.5 million series a-2 preferred financing (PDF)
December 3, 2006
Itochu Corporation and MPM Capital fund JapanBridge(Current Solasia Pharma k.k.), specialty pharmaceutical company for asian market (PDF)